BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14264176)

  • 1. CENTRAL MECHANISMS IN HEADACHE.
    DALESSIO DJ
    Headache; 1965 Jan; 5():276-8. PubMed ID: 14264176
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylaxis of frequent vascular headache with methysergide.
    HALE AR; REED AF
    Am J Med Sci; 1962 Jan; 243():92-8. PubMed ID: 13903795
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Arch Neurol; 1961 Mar; 4():235-40. PubMed ID: 13719415
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies in headache: further analysis of the mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Trans Am Neurol Assoc; 1961; 86():95-8. PubMed ID: 13883198
    [No Abstract]   [Full Text] [Related]  

  • 5. Appraisal of methysergide in treatment of vascular headaches of migraine type.
    FRIEDMAN AP; ELKIND AH
    JAMA; 1963 Apr; 184():125-8. PubMed ID: 13959785
    [No Abstract]   [Full Text] [Related]  

  • 6. THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    CROWTHER DL
    Med Exp Int J Exp Med; 1964; 10():137-43. PubMed ID: 14129849
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 8. MENIERE'S SYNDROME AND CLUSTER HEADACHES: RECURRENT PAROXYSMAL FOCAL VASODILATATION.
    GILBERT G
    JAMA; 1965 Mar; 191():691-3. PubMed ID: 14245505
    [No Abstract]   [Full Text] [Related]  

  • 9. [MEDICAL HEADACHES].
    SICUTERI F; FRANCHI G
    Aggiorn Clinico Ter; 1964 Mar; 5():1-70. PubMed ID: 14168418
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 11. CEREBRAL ARTERIOGRAPHY DURING MIGRAINE PRODROME AND HEADACHE.
    DUKES HT; VIETH RG
    Neurology; 1964 Jul; 14():636-9. PubMed ID: 14200038
    [No Abstract]   [Full Text] [Related]  

  • 12. CLINICAL STUDIES ON THE TREATMENT OF VASCULAR HEADACHES, A PROGRESS REPORT ON METHYSERGIDE (SANSERT).
    ABBOTT KH
    Headache; 1965 Jan; 5():261-71. PubMed ID: 14264174
    [No Abstract]   [Full Text] [Related]  

  • 13. [TREATMENT OF MIGRAINE AND ERYTHROPROSOPALGIA WITH METHYSERGIDE].
    HEYCK H
    Munch Med Wochenschr; 1964 Nov; 106():2213-9. PubMed ID: 14315954
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania].
    REBUCCI GG; COCCAGNA G
    Riv Neurol; 1962; 32():574-85. PubMed ID: 13973457
    [No Abstract]   [Full Text] [Related]  

  • 15. An evaluation of methysergide in the prevention of migraine and other vascular headaches.
    LANCE JW; FINE RD; CURRAN DA
    Med J Aust; 1963 Jun; 50(1)():814-8. PubMed ID: 13928400
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on headache. The responses of the bulbar conjunctival blood vessels during induced oliguria and diuresis, and their modification by UML-491.
    DALESSIO DJ; CHAPMAN LF; ZILELI T; CATTELL M; EHRLICH R; FORTUIN F; GOODELL H; WOLFF HG
    Arch Neurol; 1961 Dec; 5():590-3. PubMed ID: 13883199
    [No Abstract]   [Full Text] [Related]  

  • 17. PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES.
    SICUTERI F
    Triangle; 1963 Oct; 6():116-25. PubMed ID: 14087164
    [No Abstract]   [Full Text] [Related]  

  • 18. USE OF METHYSERGIDE IN THE TREATMENT OF EXTRACRANIAL VASCULAR HEADACHE.
    LOVSHIN LL
    Headache; 1963 Oct; 3():107-11. PubMed ID: 14094106
    [No Abstract]   [Full Text] [Related]  

  • 19. The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.
    LEIGH WE
    S Afr Med J; 1963 Jun; 37():631-7. PubMed ID: 13929429
    [No Abstract]   [Full Text] [Related]  

  • 20. FATAL INFARCTION OF THE BRAIN IN MIGRAINE.
    GUEST IA; WOOLF AL
    Br Med J; 1964 Jan; 1(5377):225-6. PubMed ID: 14074182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.